“Down” is street slang for illegal opioids, most commonly fentanyl, heroin, or a mix of both. The term comes from the drug’s effect: it slows (or brings “down”) the central nervous system, producing sedation, pain relief, and euphoria. In today’s unregulated drug market, what’s sold as “down” rarely contains just one substance. It’s frequently cut with synthetic sedatives, animal tranquilizers, and other fillers that make it cheaper to produce and far more dangerous to use.
What “Down” Actually Contains
A decade ago, down typically meant heroin. That’s no longer the case. Illicitly manufactured fentanyl has largely replaced heroin in the street supply across North America. Fentanyl is roughly 50 times more potent than heroin by weight, which means the margin between a dose that produces a high and a dose that kills is extremely thin. According to DEA laboratory analyses from 2024, the average fentanyl pill seized contained 1.94 milligrams of fentanyl, and roughly 5 out of 10 counterfeit pills contained 2 milligrams or more. Fentanyl powder samples varied wildly, from nearly 0% to 82% purity, meaning two batches from the same dealer can differ dramatically in strength.
Beyond fentanyl itself, down increasingly contains synthetic benzodiazepines, a trend sometimes called “benzo-dope.” These are lab-made sedatives mixed into the opioid supply, often without the buyer’s knowledge. In 2021, nearly 14% of opioid overdose deaths in the U.S. also involved benzodiazepines. The combination is especially dangerous because both classes of drugs suppress breathing through different mechanisms, and the standard overdose reversal medication only works on the opioid portion.
Xylazine, a veterinary sedative never approved for human use, has also turned up in the down supply. Xylazine slows breathing, heart rate, and blood pressure to dangerously low levels on its own. Mixed with fentanyl, it deepens sedation and creates a longer-lasting high that dealers use to stretch their product. It also causes severe skin wounds at and away from injection sites, a problem not seen with opioids alone.
How It Affects the Body
Opioids work by binding to specific receptors in the brain and spinal cord. When those receptors are activated, they block pain signals, trigger a rush of euphoria, slow gut movement, constrict the pupils, and, critically, suppress the brain’s drive to breathe. At low doses this produces the warm, drowsy sensation users seek. At higher doses, or when combined with other depressants, breathing can slow to the point of stopping entirely.
Synthetic benzodiazepines amplify this problem through a separate pathway. They boost the activity of a brain chemical called GABA, which acts like a brake pedal for nerve cells. More GABA activity means deeper sedation, muscle relaxation, and further respiratory suppression. When an opioid and a benzodiazepine hit the brain simultaneously, the two braking systems stack on top of each other. This is why benzo-laced down carries a sharply higher overdose risk than fentanyl alone.
Xylazine adds a third layer of sedation through yet another mechanism, lowering heart rate and blood pressure independently. The result is a cocktail where each ingredient compounds the danger of the others.
Signs of a Down Overdose
The hallmark signs are slow or stopped breathing, pinpoint pupils, blue or grayish skin (especially around the lips and fingertips), limpness, and unresponsiveness. A person may make gurgling or snoring sounds, which indicate the airway is partially blocked. If xylazine or benzodiazepines are involved, the person may remain deeply unconscious even longer than a typical opioid overdose would cause.
One important distinction: opioid overdoses generally don’t cause seizures, but some of the synthetic benzodiazepines found in today’s supply can trigger them during withdrawal. So someone who seems to recover from an overdose may still face complications hours later.
Why Naloxone Helps but Has Limits
Naloxone (commonly known by the brand name Narcan) reverses opioid overdoses by knocking opioids off their receptors in the brain. It works within minutes and can restore normal breathing. For a fentanyl overdose, multiple doses are sometimes needed because fentanyl binds tightly to those receptors.
The catch is that naloxone only reverses the opioid component. It does nothing against benzodiazepines or xylazine. If someone has taken benzo-laced down, naloxone may partially restore breathing but leave the person deeply sedated. If xylazine is involved, the dangerously low heart rate and blood pressure will persist even after naloxone is given. This is why emergency responders now treat naloxone as a first step rather than a complete solution. If someone doesn’t wake up after naloxone, the presence of non-opioid depressants is a likely reason.
Testing Before Use
Because down’s composition varies from batch to batch, harm reduction programs now distribute test strips that can detect specific adulterants. Fentanyl test strips have been widely available for several years and can confirm whether a sample contains fentanyl. Newer xylazine test strips work by dissolving a small amount of the drug in clean water, dipping the strip for 5 to 10 seconds, and reading the result after 5 minutes. Benzodiazepine test strips also exist, though they were originally designed for urine screening and may be less commonly stocked at harm reduction sites.
These strips can’t tell you how much of a substance is present, only whether it’s there. A positive fentanyl result doesn’t distinguish between a weak batch and an extremely potent one. Still, knowing that xylazine or a benzodiazepine is in the mix changes the risk picture significantly and can inform decisions about dosing, having naloxone nearby, and not using alone.
Why the Supply Keeps Getting More Dangerous
The shift from heroin to fentanyl was driven by economics. Fentanyl is synthesized in a lab rather than grown from poppy fields, making it cheaper and easier to produce in large quantities. Dealers stretch their product further by adding sedatives like synthetic benzodiazepines and xylazine, which are inexpensive and intensify the perceived high without adding more fentanyl. The result is a supply where the buyer has almost no way to gauge potency or composition by appearance, smell, or taste. Two identical-looking bags from the same source can contain entirely different concentrations and combinations of drugs.
This unpredictability is the core reason overdose rates have climbed so steeply. It’s not that users are necessarily taking more; it’s that what they’re taking changes constantly, and the body has no way to prepare for a dose that’s twice as strong as yesterday’s or laced with a sedative that naloxone can’t touch.